PERFUSION SYSTEMS BIO-MEDICUS NG ARTERIAL CANNULA; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO
|
Back to Search Results |
|
Model Number 96570-119 |
Device Problems
Component Missing (2306); Misassembled During Installation (4049)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/15/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that prior to use of a bio-medicus nextgen femoral arterial cannula, it was reported that when the c annulae were opened to the sterile field, they were found to have a very long introducers inconsistent with that cannula model and no clear hemostasis caps.The devices were not used.There was no patient involvement, so no adverse effect occurred.Medtronic received additional information that there were no adverse patient effects.The issue with both the cannula were identified during the same procedure.Medtronic received additional information that the issue was identified as soon as the packaging was opened.The cannula was not attempted to be used with the incorrect introducer.The hemostasis cap was not provided.Medtronic received additional information that the blood residue is from bloody gloves handling the cannula.
|
|
Search Alerts/Recalls
|
|
|